Dihydrosanguinarine
Dihydrosanguinarine is a benzophenanthridine alkaloid derived from the Papaveraceae family of plants. It is a naturally occurring compound with potential therapeutic applications in the field of medicine and pharmacology.
Chemical Structure[edit]
Dihydrosanguinarine has a complex chemical structure, characterized by a benzophenanthridine skeleton. This structure is common to a group of alkaloids known as the benzophenanthridine alkaloids, which also includes sanguinarine, chelerythrine, and macarpine.
Pharmacological Properties[edit]
Dihydrosanguinarine exhibits a range of pharmacological properties. It has been studied for its potential anti-cancer, anti-inflammatory, and anti-microbial effects.
Anti-Cancer Properties[edit]
Dihydrosanguinarine has been shown to inhibit the growth of certain types of cancer cells in vitro. This is thought to be due to its ability to interfere with the cell cycle and induce apoptosis, or programmed cell death.
Anti-Inflammatory Properties[edit]
In addition to its potential anti-cancer effects, dihydrosanguinarine also exhibits anti-inflammatory properties. It has been shown to inhibit the production of pro-inflammatory cytokines, which are small proteins that play a key role in the body's inflammatory response.
Anti-Microbial Properties[edit]
Dihydrosanguinarine has also been studied for its potential anti-microbial effects. It has been shown to exhibit activity against a range of bacteria and fungi, suggesting potential applications in the treatment of infectious diseases.
Potential Therapeutic Applications[edit]
Given its range of pharmacological properties, dihydrosanguinarine has potential therapeutic applications in a number of areas. These include the treatment of cancer, inflammatory diseases, and infectious diseases. However, further research is needed to fully understand the potential of this compound and to develop it into a clinically useful drug.
See Also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
